Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors
- Roshani R. Patel
- , Surojeet Sengupta
- , Helen R. Kim
- , Andrés J.P. Klein-Szanto
- , Jennifer R. Pyle
- , Fang Zhu
- , Tianyu Li
- , Eric A. Ross
- , Salewa Oseni
- , Joseph Fargnoli
- , V. Craig Jordan
- Dartmouth-Hitchcock Medical Center
- Georgetown University
- Bristol-Myers Squibb
- Fox Chase Cancer Center
Research output: Contribution to journal › Article › peer-review
43
Scopus
citations